Page 64 - TD-4-3

Tumor Discovery Prognostication in palliative cancer care

inflammation-based prognostic system. Clin Cancer Res. The surprise question and clinician-predicted prognosis:
2013;19(19):5456-5464. Systematic review and meta-analysis. BMJ Support Palliat
Care. 2024;15:12-35.
doi: 10.1158/1078-0432.CCR-13-1066
doi: 10.1136/spcare-2024-004879
41. Laird BJ, Fallon M, Hjermstad MJ, et al. Quality of life in
patients with advanced cancer: Differential association with 52. Nauck F, Alt-Epping B. Crises in palliative care--a
performance status and systemic inflammatory response. comprehensive approach. Lancet Oncol. 2008;9(11):
J Clin Oncol. 2016;34(23):2769-2775. 1086-1091.
doi: 10.1200/JCO.2015.65.7742 doi: 10.1016/S1470-2045(08)70278-X
42. Simmons CP, Koinis F, Fallon MT, et al. Prognosis in 53. Liu B, Zhou H, Tan L, Siu KTH, Guan XY. Exploring
advanced lung cancer--a prospective study examining key treatment options in cancer: Tumor treatment strategies.
clinicopathological factors. Lung Cancer. 2015;88(3):304-309. Signal Transduct Target Ther. 2024;9(1):175.
doi: 10.1016/j.lungcan.2015.03.020 doi: 10.1038/s41392-024-01856-7
43. Hui D, Ross J, Park M, et al. Predicting survival in patients 54. Allende-Perez S, Rodriguez-Mayoral O, Pena-Nieves A,
with advanced cancer in the last weeks of life: How accurate Bruera E. Performance status and survival in cancer patients
are prognostic models compared to clinicians’ estimates? undergoing palliative care: Retrospective study. BMJ Support
Palliat Med. 2020;34(1):126-133. Palliat Care. 2024;14:1256-1262.
doi: 10.1177/0269216319873261 doi: 10.1136/spcare-2022-003562
44. Scarpi E, Maltoni M, Miceli R, et al. Survival prediction 55. Tas F, Sen F, Odabas H, Kilic L, Keskin S, Yildiz I. Performance
for terminally ill cancer patients: Revision of the palliative status of patients is the major prognostic factor at all stages
prognostic score with incorporation of delirium. Oncologist. of pancreatic cancer. Int J Clin Oncol. 2013;18(5):839-846.
2011;16(12):1793-1799.
doi: 10.1007/s10147-012-0474-9
doi: 10.1634/theoncologist.2011-0130
56. Carey MS, Bacon M, Tu D, Butler L, Bezjak A, Stuart GC.
45. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. The prognostic effects of performance status and quality
Palliative performance scale (PPS): A new tool. J Palliat of life scores on progression-free survival and overall
Care. 1996;12(1):5-11. survival in advanced ovarian cancer. Gynecol Oncol.
2008;108(1):100-105.
46. Morita T, Tsunoda J, Inoue S, Chihara S. The palliative
prognostic index: A scoring system for survival prediction doi: 10.1016/j.ygyno.2007.08.088
of terminally ill cancer patients. Support Care Cancer. 57. Hsu CY, Lee YH, Hsia CY, et al. Performance status in
1999;7(3):128-133.
patients with hepatocellular carcinoma: Determinants,
doi: 10.1007/s005200050242 prognostic impact, and ability to improve the Barcelona
clinic liver cancer system. Hepatology. 2013;57(1):112-119.
47. Pirovano M, Maltoni M, Nanni O, et al. A new palliative
prognostic score: A first step for the staging of terminally doi: 10.1002/hep.25950
ill cancer patients. Italian multicenter and study group on 58. Jung EH, Hiratsuka Y, Suh SY, et al. Clinicians’ prediction of
palliative care. J Pain Symptom Manage. 1999;17(4):231-239.
survival is most useful for palliative care referral. Palliat Med
doi: 10.1016/s0885-3924(98)00145-6 Rep. 2024;5(1):365-372.
48. Feliu J, Jimenez-Gordo AM, Madero R, et al. Development doi: 10.1089/pmr.2024.0013
and validation of a prognostic nomogram for terminally ill 59. Dahabreh IJ, Hayward R, Kent DM. Using group data to
cancer patients. J Natl Cancer Inst. 2011;103(21):1613-1620.
treat individuals: Understanding heterogeneous treatment
doi: 10.1093/jnci/djr388 effects in the age of precision medicine and patient-centred
evidence. Int J Epidemiol. 2016;45(6):2184-2193.
49. Gwilliam B, Keeley V, Todd C, et al. Development of
prognosis in palliative care study (PiPS) predictor models doi: 10.1093/ije/dyw125
to improve prognostication in advanced cancer: Prospective 60. Coussens LM, Werb Z. Inflammation and cancer. Nature.
cohort study. BMJ. 2011;343:d4920.
2002;420(6917):860-867.
doi: 10.1136/bmj.d4920
doi: 10.1038/nature01322
50. Chu C, White N, Stone P. Prognostication in palliative care. 61. Moen MK, Lohre ET, Jakobsen G, Thronaes M, Klepstad P.
Clin Med (Lond). 2019;19(4):306-310.
Antibiotic therapy in integrated oncology and palliative cancer
doi: 10.7861/clinmedicine.19-4-306 care: An observational study. Cancers (Basel). 2022;14(7):1602.
51. Gupta A, Burgess R, Drozd M, Gierula J, Witte K, Straw S. doi: 10.3390/cancers14071602

Volume 4 Issue 3 (2025) 56 doi: 10.36922/td.8576